Albert Yick Hou Lim

Albert Yick Hou Lim

Auto-generated profile, based on publicly available information

Albert Yick Hou Lim

Department of Respiratory and Critical Care Medicine Tan Tock Seng Hospital Singapore Singapore

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 May 2018 in BMC Pulmonary Medicine
Verified
Journal Article
Open access
PDF file
ALAlbert Y. H. Lim
Albert Y. H. Lim
SCSanjay Haresh Chotirmall
Sanjay Haresh Chotirmall
EFEric T. K. Fok
Eric T. K. Fok
AVAkash Verma
Akash Verma
PDPartha P. De
Partha P. De
JAJohn A. Abisheganaden
John A. Abisheganaden
Non-tuberculous mycobacteria (NTM) infection is an increasing problem worldwide. The epidemiology of NTM in most Asian countries is unknown. This study investigated the epidemiology, and clinical profile of inpatients in whom NTM was isolated from various anatomical sites in a Singaporean population attending a major tertiary referral centre. Demographic profile, clinical data, and characteristics of patients hospitalized with NTM isolates at a major tertiary hospital over two-year period were prospectively assessed (2011–2012). Data collected included patient demographics, ethnicity, smoking status, co-morbidities, NTM species, intensive care unit (ICU) treatment, and mortality. A total of 485 patients (62.1% male) with 560 hospital admissions were analysed. The median patient age was 70 years. Thirteen different NTM species were isolated from this cohort. Mycobacterium abscessus (M. abscessus) (38.4%) was most frequently isolated followed by Mycobacterium fortuitum (M. fortuitum) (16.6%), Mycobacterium avium complex (MAC) (16.3%), Mycobacterium kansasii (M. kansasii) (15.4%), and Mycobacterium gordonae (M. gordonae) (6.8%). Most (91%) NTM was isolated from the respiratory tract. The three most common non-pulmonary sites were; blood (2.7%), skin wounds and abscesses (2.1%), and gastric aspirates (1.1%). A third (34.4%) of the study population had prior pulmonary tuberculosis (PTB). There was a significant association between isolated NTM species, and patient age (p = 0.0002). Eleven (2.2%) patients received intensive care unit (ICU) treatment during the study period and all cause mortality within 1 year of the study was 16.9% (n = 82). Of these, 72 (87.8%) patients died of pulmonary causes. The profile of NTM species in Singapore is unique. M. abscessus is the commonest NTM isolated, with a higher prevalence in males, and in the elderly. High NTM prevalence is associated with high rates of prior PTB in our cohort.

12 August 2021 in ERJ Open Research
Verified
Journal Article
Open access
PDF file
HPHwee Pin Phua
Hwee Pin Phua
WLWei-Yen Lim
Wei-Yen Lim
GGGanga Ganesan
Ganga Ganesan
JYJoanne Su Yin Yoong
Joanne Su Yin Yoong
KTKelvin Bryan Tan
Kelvin Bryan Tan
ALAlbert Yick Hou Lim
Albert Yick Hou Lim
Background and objective Little is known about the epidemiology and cost of bronchiectasis in Asia. This study describes the disease burden of bronchiectasis in Singapore. Methods A nationwide administrative dataset was used to identify hospitalisations with bronchiectasis as a diagnosis. Population statistics and medical encounter data were used to estimate the incidence, mortality, prevalence and direct medical costs associated with hospitalisation-requiring bronchiectasis. Results There were 420 incident hospitalised bronchiectasis patients in 2017, giving an incidence rate of 10.6/100 000. Age-standardised incidence declined on average by 2.7% per year between 2007 and 2017. Incidence rates increased strongly with age in both men and women. Tuberculosis was a secondary diagnosis in 37.5% of incident hospitalisations in 2007, but has declined sharply since then. Patient survival was considerably lower in both men (5-year Relative Survival Ratios (RSR) of 0.63 (95% CI, 0.59 to 0.66)) and women ((5-year RSR of 0.75 (95% CI, 0.72 to 0.78)). The point prevalence of bronchiectasis was 147.1/100,000 in 2017, and increased sharply with age, with more than 1% of people aged 75 years and older having bronchiectasis. Total first-year costs among incident bronchiectasis patients in 2016 varied widely, with an average of $7331 (standard deviation of $8863). About 10% of the patients admitted in 2016 had total first-year costs of more than $14 380. Conclusion Bronchiectasis is common and imposes a substantial burden on health care costs and survival rates of patients in Singapore.

22 January 2021 in BMC Pulmonary Medicine
Verified
Journal Article
Open access
PDF file
ALAlbert Yick Hou Lim
Albert Yick Hou Lim
JGJun Leng Goh
Jun Leng Goh
MCMae Chui Wei Chua
Mae Chui Wei Chua
BHBee Hoon Heng
Bee Hoon Heng
JAJohn Arputham Abisheganaden
John Arputham Abisheganaden
PGPradeep Paul George
Pradeep Paul George
Background: COVID-19 is a systemic viral infection which mainly targets the human respiratory system with many secondary clinical manifestations especially affecting the hematopoietic system and haemostasis. Few studies have highlighted the prognostic value of blood findings such as lymphopenia, neutrophil/lymphocyte ratio, platelet/lymphocyte ratio, LDH, CRP, cardiac troponin, low-density lipoproteins and chest radiographic abnormality. A study of progressions of blood and radiological results may help to identify patients at high risk of severe outcomes. This systematic review aimed to assess the temporal progression of blood and radiology findings of patients with COVID-19. Methods: Comprehensive systematic literature search was conducted on Medline, Embase and Cochrane databases to identify articles published for peripheral blood investigation and radiological results of COVID-19 patients. Results: A total of 27 studies were included in this review. The common laboratory features reported include lymphopenia, elevated levels of C-reactive proteins and lactate dehydrogenase. For radiological signs, ground-glass opacifications, consolidations, and crazy paving patterns were frequently reported. There is a correlation between lymphocyte count, neutrophil count and biomarkers such as C-reactive proteins and lactate dehydrogenase; at a later phase of the disease (more than 7 days since onset of symptoms), lymphopenia worsens while neutrophil count, C-reactive protein levels and lactate dehydrogenase levels increase. Frequencies of ground-glass opacifications and ground-glass opacifications with consolidations decrease at a later phase of the disease while that of consolidation and crazy paving pattern rises as the disease progresses. More extensive lung involvement was also seen more frequently in the later phases. Conclusion: The correlation between temporal progression and the reported blood and radiological results may be helpful to monitor and evaluate disease progression and severity.

1 December 2016 in Medicine
Verified
Journal Article
Open access
AVAkash Mrcp Verma
Akash Mrcp Verma
KGKee San Goh
Kee San Goh
CPChee Kiang Phua
Chee Kiang Phua
WSWen Yuan Sim
Wen Yuan Sim
KTKuan Sen Tee
Kuan Sen Tee
JAJohn Abisheganaden
John Abisheganaden
To compare the performance of convex probe endobronchial ultrasound guided transbronchial needle aspiration (EBUS-TBNA) with conventional endobronchial biopsy (EBB) or transbronchial lung biopsy (TBLB) in patients with mediastinal, and coexisting endobronchial or peripheral lesions. Retrospective review of records of patients undergoing diagnostic EBUS-TBNA and conventional bronchoscopy in 2014. A total of 74 patients had mediastinal, and coexisting endobronchial or peripheral lesions. The detection rate of EBUS-TBNA for mediastinal lesion >1 cm in short axis, EBB for visible exophytic type of endobronchial lesion, and TBLB for peripheral lesion with bronchus sign were 71%, 75%, and 86%, respectively. In contrast, the detection rate of EBUS-TBNA for mediastinal lesion ≤1 cm in short axis, EBB for mucosal hyperemia type of endobronchial lesion, and TBLB for peripheral lesion without bronchus sign were 25%, 63%, and 38%, and improved to 63%, 88%, and 62% respectively by adding EBB or TBLB to EBUS-TBNA, and EBUS-TBNA to EBB or TBLB. Postprocedure bleeding was significantly more common in patients undergoing EBB and TBLB 8 (40%) versus convex probe EBUS-TBNA 2 patients (2.7%, P = 0.0004). EBUS-TBNA is a safer single diagnostic technique compared with EBB or TBLB in patients with mediastinal lesion of >1 cm in size, and coexisting exophytic type of endobronchial lesion, or peripheral lesion with bronchus sign. However, it requires combining with EBB or TBLB and vice versa to optimize yield when mediastinal lesion is ≤1 cm in size, and coexisting endobronchial and peripheral lesions lack exophytic nature, and bronchus sign, respectively.

19 November 2021 in Respirology
Verified
Journal Article
Open access
PDF file
NPNesia Priandari
Nesia Priandari
WWWiwien Heru Wiyono
Wiwien Heru Wiyono
FYFaisal Yunus
Faisal Yunus
BABudhi Antariksa
Budhi Antariksa
FIFathiyah Isbaniah
Fathiyah Isbaniah
HLHui Fang Lim
Hui Fang Lim
Click on the article title to read more.

28 July 2016 in Current Respiratory Medicine Reviews
Verified
Journal Article
Closed access
AVAkash Verma
Akash Verma
CPChee K. Phua
Chee K. Phua
WSWen Y. Sim
Wen Y. Sim
ALAlbert Y.H. Lim
Albert Y.H. Lim
DTDessmon Y.H. Tai
Dessmon Y.H. Tai
JAJohn Abisheganaden
John Abisheganaden